A Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology Setting

Clinical trial NCT05210010 · UNKNOWN

Trial details

NCT number: NCT05210010
Sponsor: Ensho Health Intelligent Systems Inc.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Transthyretin Amyloid Cardiomyopathy ("ATTR-CM")

Start date: 2021-11-01
Primary completion: 2022-05-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.